HSD17B13


Description

The HSD17B13 (hydroxysteroid 17-beta dehydrogenase 13) is a protein-coding gene located on chromosome 4.

17β-Hydroxysteroid dehydrogenase type 13 (also known as 17β-HSD type 13) is an enzyme that in humans is encoded by the HSD17B13 gene. It is significantly up-regulated in the liver of patients with non-alcoholic fatty liver disease (NAFLD) and enhances lipogenesis.

In 2023, the first potent and selective HSD17B13 inhibitor, BI-3231, was reported. The inhibitor meets the quality criteria of a 'Donated Chemical Probe' as defined by the Structural Genomics Consortium.

HSD17B13 is also known as FLDP, HMFN0376, NIIL497, SCDR9, SDR16C3.

Associated Diseases



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.